ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) Stock Fundamental Analysis

BIT:1ROG • CH0012032048

398 EUR
+24 (+6.42%)
Last: Feb 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Overall 1ROG gets a fundamental rating of 5 out of 10. We evaluated 1ROG against 52 industry peers in the Pharmaceuticals industry. While 1ROG has a great profitability rating, there are some minor concerns on its financial health. 1ROG is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • 1ROG had positive earnings in the past year.
  • In the past year 1ROG had a positive cash flow from operations.
  • 1ROG had positive earnings in 4 of the past 5 years.
  • 1ROG had a positive operating cash flow in 4 of the past 5 years.
1ROG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ROG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

  • 1ROG has a Return On Assets of 9.95%. This is in the better half of the industry: 1ROG outperforms 71.15% of its industry peers.
  • 1ROG has a Return On Equity of 32.88%. This is amongst the best in the industry. 1ROG outperforms 86.54% of its industry peers.
  • The Return On Invested Capital of 1ROG (24.24%) is better than 92.31% of its industry peers.
  • 1ROG had an Average Return On Invested Capital over the past 3 years of 23.72%. This is significantly above the industry average of 14.12%.
  • The 3 year average ROIC (23.72%) for 1ROG is below the current ROIC(24.24%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.95%
ROE 32.88%
ROIC 24.24%
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
1ROG.MI Yearly ROA, ROE, ROIC1ROG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • Looking at the Profit Margin, with a value of 15.31%, 1ROG is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 1ROG has declined.
  • 1ROG has a Operating Margin of 33.79%. This is amongst the best in the industry. 1ROG outperforms 88.46% of its industry peers.
  • In the last couple of years the Operating Margin of 1ROG has remained more or less at the same level.
  • 1ROG has a Gross Margin of 73.92%. This is in the better half of the industry: 1ROG outperforms 71.15% of its industry peers.
  • In the last couple of years the Gross Margin of 1ROG has remained more or less at the same level.
Industry RankSector Rank
OM 33.79%
PM (TTM) 15.31%
GM 73.92%
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
1ROG.MI Yearly Profit, Operating, Gross Margins1ROG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1ROG is creating value.
  • There is no outstanding debt for 1ROG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1ROG.MI Yearly Shares Outstanding1ROG.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1ROG.MI Yearly Total Debt VS Total Assets1ROG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • An Altman-Z score of 4.78 indicates that 1ROG is not in any danger for bankruptcy at the moment.
  • 1ROG has a better Altman-Z score (4.78) than 65.38% of its industry peers.
  • The Debt to FCF ratio of 1ROG is 2.50, which is a good value as it means it would take 1ROG, 2.50 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of 1ROG (2.50) is better than 76.92% of its industry peers.
  • 1ROG has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of 1ROG (1.06) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 2.5
Altman-Z 4.78
ROIC/WACC4.83
WACC5.02%
1ROG.MI Yearly LT Debt VS Equity VS FCF1ROG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

  • 1ROG has a Current Ratio of 1.29. This is a normal value and indicates that 1ROG is financially healthy and should not expect problems in meeting its short term obligations.
  • 1ROG's Current ratio of 1.29 is in line compared to the rest of the industry. 1ROG outperforms 50.00% of its industry peers.
  • A Quick Ratio of 1.02 indicates that 1ROG should not have too much problems paying its short term obligations.
  • 1ROG's Quick ratio of 1.02 is in line compared to the rest of the industry. 1ROG outperforms 59.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.02
1ROG.MI Yearly Current Assets VS Current Liabilites1ROG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 3.51% over the past year.
  • The Earnings Per Share has been growing slightly by 0.31% on average over the past years.
EPS 1Y (TTM)3.51%
EPS 3Y-1.4%
EPS 5Y0.31%
EPS Q2Q%-2.45%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.24%

3.2 Future

  • Based on estimates for the next years, 1ROG will show a small growth in Earnings Per Share. The EPS will grow by 7.79% on average per year.
  • Based on estimates for the next years, 1ROG will show a small growth in Revenue. The Revenue will grow by 3.83% on average per year.
EPS Next Y7.31%
EPS Next 2Y6.74%
EPS Next 3Y6.31%
EPS Next 5Y7.79%
Revenue Next Year2.76%
Revenue Next 2Y2.93%
Revenue Next 3Y2.86%
Revenue Next 5Y3.83%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1ROG.MI Yearly Revenue VS Estimates1ROG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
1ROG.MI Yearly EPS VS Estimates1ROG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.65 indicates a rather expensive valuation of 1ROG.
  • 61.54% of the companies in the same industry are more expensive than 1ROG, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.11. 1ROG is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 17.38, 1ROG is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ROG indicates a somewhat cheap valuation: 1ROG is cheaper than 63.46% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.13. 1ROG is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.65
Fwd PE 17.38
1ROG.MI Price Earnings VS Forward Price Earnings1ROG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1ROG is valued a bit cheaper than the industry average as 63.46% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ROG indicates a somewhat cheap valuation: 1ROG is cheaper than 67.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.25
EV/EBITDA 12.93
1ROG.MI Per share data1ROG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • 1ROG has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.55
PEG (5Y)59.93
EPS Next 2Y6.74%
EPS Next 3Y6.31%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.70%, 1ROG has a reasonable but not impressive dividend return.
  • 1ROG's Dividend Yield is a higher than the industry average which is at 1.89.
  • 1ROG's Dividend Yield is a higher than the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 2.7%

5.2 History

  • The dividend of 1ROG has a limited annual growth rate of 2.37%.
Dividend Growth(5Y)2.37%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1ROG pays out 85.87% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of 1ROG is growing, but earnings are growing more, so the dividend growth is sustainable.
DP85.87%
EPS Next 2Y6.74%
EPS Next 3Y6.31%
1ROG.MI Yearly Income VS Free CF VS Dividend1ROG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
1ROG.MI Dividend Payout.1ROG.MI Dividend Payout, showing the Payout Ratio.1ROG.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ROCHE HOLDING AG-GENUSSCHEIN

BIT:1ROG (2/11/2026, 7:00:00 PM)

398

+24 (+6.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners40.79%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap322.08B
Revenue(TTM)N/A
Net Income(TTM)9.43B
Analysts71.72
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.7%
Yearly Dividend11.07
Dividend Growth(5Y)2.37%
DP85.87%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.7%
EPS NY rev (3m)0.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.19%
Valuation
Industry RankSector Rank
PE 18.65
Fwd PE 17.38
P/S 4.77
P/FCF 22.25
P/OCF 15.23
P/B 10.24
P/tB 67.58
EV/EBITDA 12.93
EPS(TTM)21.34
EY5.36%
EPS(NY)22.9
Fwd EY5.75%
FCF(TTM)17.89
FCFY4.49%
OCF(TTM)26.13
OCFY6.56%
SpS83.46
BVpS38.86
TBVpS5.89
PEG (NY)2.55
PEG (5Y)59.93
Graham Number136.6
Profitability
Industry RankSector Rank
ROA 9.95%
ROE 32.88%
ROCE 30.98%
ROIC 24.24%
ROICexc 25.87%
ROICexgc 40.74%
OM 33.79%
PM (TTM) 15.31%
GM 73.92%
FCFM 21.43%
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
ROICexc(3y)28.94%
ROICexc(5y)29.11%
ROICexgc(3y)49.53%
ROICexgc(5y)49.86%
ROCE(3y)29.26%
ROCE(5y)30.68%
ROICexgc growth 3Y2.54%
ROICexgc growth 5Y-3.21%
ROICexc growth 3Y1.27%
ROICexc growth 5Y-3.5%
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 2.5
Debt/EBITDA 1.25
Cap/Depr 175.31%
Cap/Sales 9.87%
Interest Coverage 17.17
Cash Conversion 79.41%
Profit Quality 140.01%
Current Ratio 1.29
Quick Ratio 1.02
Altman-Z 4.78
F-Score8
WACC5.02%
ROIC/WACC4.83
Cap/Depr(3y)132.99%
Cap/Depr(5y)129.62%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.42%
Profit Quality(3y)129.49%
Profit Quality(5y)117.9%
High Growth Momentum
Growth
EPS 1Y (TTM)3.51%
EPS 3Y-1.4%
EPS 5Y0.31%
EPS Q2Q%-2.45%
EPS Next Y7.31%
EPS Next 2Y6.74%
EPS Next 3Y6.31%
EPS Next 5Y7.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.24%
Revenue Next Year2.76%
Revenue Next 2Y2.93%
Revenue Next 3Y2.86%
Revenue Next 5Y3.83%
EBIT growth 1Y10.03%
EBIT growth 3Y2.72%
EBIT growth 5Y-0.14%
EBIT Next Year23.19%
EBIT Next 3Y10.25%
EBIT Next 5Y8.97%
FCF growth 1Y12.91%
FCF growth 3Y-2.8%
FCF growth 5Y-2.91%
OCF growth 1Y19.07%
OCF growth 3Y-1.42%
OCF growth 5Y-2.14%

ROCHE HOLDING AG-GENUSSCHEIN / 1ROG.MI FAQ

Can you provide the ChartMill fundamental rating for ROCHE HOLDING AG-GENUSSCHEIN?

ChartMill assigns a fundamental rating of 5 / 10 to 1ROG.MI.


What is the valuation status for 1ROG stock?

ChartMill assigns a valuation rating of 4 / 10 to ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for ROCHE HOLDING AG-GENUSSCHEIN?

ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) has a profitability rating of 7 / 10.


What is the valuation of ROCHE HOLDING AG-GENUSSCHEIN based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) is 18.65 and the Price/Book (PB) ratio is 10.24.


What is the expected EPS growth for ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) stock?

The Earnings per Share (EPS) of ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) is expected to grow by 7.31% in the next year.